Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

ABSTRACT Quantifying the benefit of early antibiotic treatment is crucial for decision making and can be assessed only in observational studies. We performed a systematic review of prospective studies reporting the effect of appropriate empirical antibiotic treatment on all-cause mortality among adult inpatients with sepsis. Two reviewers independently extracted data. Risk of bias was assessed using the Newcastle-Ottawa score. We calculated unadjusted odds ratios (ORs) with 95% confidence intervals for each study and extracted adjusted ORs, with variance, methods, and covariates being used for adjustment. ORs were pooled using random-effects meta-analysis. We examined the effects of methodological and clinical confounders on results through subgroup analysis or mixed-effect meta-regression. Seventy studies were included, of which 48 provided an adjusted OR for inappropriate empirical antibiotic treatment. Inappropriate empirical antibiotic treatment was associated with significantly higher mortality in the unadjusted and adjusted comparisons, with considerable heterogeneity occurring in both analyses (I2 > 70%). Study design, time of mortality assessment, the reporting methods of the multivariable models, and the covariates used for adjustment were significantly associated with effect size. Septic shock was the only clinical variable significantly affecting results (it was associated with higher ORs). Studies adjusting for background conditions and sepsis severity reported a pooled adjusted OR of 1.60 (95% confidence interval = 1.37 to 1.86; 26 studies; number needed to treat to prevent one fatal outcome, 10 patients [95% confidence interval = 8 to 15]; I2 = 46.3%) given 34% mortality with inappropriate empirical treatment. Appropriate empirical antibiotic treatment is associated with a significant reduction in all-cause mortality. However, the methods used in the observational studies significantly affect the effect size reported. Methods of observational studies assessing the effects of antibiotic treatment should be improved and standardized.

[1]  Claude D Martin,et al.  Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome* , 2003, Critical care medicine.

[2]  Stephan Harbarth,et al.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. , 2003, The American journal of medicine.

[3]  J. Miro,et al.  Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. , 1988, Reviews of infectious diseases.

[4]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[5]  Á. Pascual,et al.  Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas , 2003 .

[6]  L. Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[7]  F. Ballester,et al.  Epidemiology of Sepsis in the Valencian Community (Spain), 1995–2004 , 2008, Infection Control & Hospital Epidemiology.

[8]  G. Richards,et al.  The epidemiology of sepsis. , 1973, Clinical orthopaedics and related research.

[9]  F. J. Caballero,et al.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  F. Saulnier,et al.  Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome* , 2006, Critical care medicine.

[11]  G. Parmigiani,et al.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Leibovici,et al.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.

[13]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[14]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[15]  Patricia Muñoz,et al.  Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Steen Andreassen,et al.  Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. , 2006, The Journal of antimicrobial chemotherapy.

[17]  Jessina C. McGregor,et al.  Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points , 2008, Infection Control & Hospital Epidemiology.

[18]  M. Meisner,et al.  Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia , 2006, Critical care.

[19]  C S Bryan,et al.  Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. , 1983, Reviews of infectious diseases.

[20]  Julian P. T. Higgins,et al.  Meta-Regression in Stata , 2008 .

[21]  J. Gómez,et al.  Clinical significance of pneumococcal bacteraemias in a general hospital: a prospective study 1989-1993. , 1995, The Journal of antimicrobial chemotherapy.

[22]  Y. Carmeli,et al.  Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients , 2010, Antimicrobial Agents and Chemotherapy.

[23]  J. A. H. Martínez,et al.  Bacteriemias por P. aeruginosa: anlisis de los factores pronstico. Estudio prospectivo 1992-1998 , 2004 .

[24]  P. Montravers,et al.  Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Claude D Martin,et al.  Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse* , 2007, Critical care medicine.

[26]  Steen Andreassen,et al.  The TREAT project: decision support and prediction using causal probabilistic networks. , 2007, International journal of antimicrobial agents.

[27]  R. Zaragoza,et al.  The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  Jessina C. McGregor,et al.  Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study , 2008, BMC infectious diseases.

[29]  M. Kollef,et al.  Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. , 2004, Chest.

[30]  Yee-Chun Chen,et al.  Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[31]  Fabio Salamanca-Gómez,et al.  Roberto Martínez Martínez , 2011 .

[32]  J. Rodríguez-Baño,et al.  [Acinetobacter baumannii bacteremia: clinical and prognostic features]. , 2003, Enfermedades infecciosas y microbiologia clinica.

[33]  S. Andreassen,et al.  Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. , 2006, The American journal of medicine.

[34]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[35]  A. Connor,et al.  The way I see it: House officers need formal career development , 2002 .

[36]  Á. Soriano,et al.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  K. Kaye,et al.  Risk factors for ineffective therapy in patients with bloodstream infection. , 2005, Archives of internal medicine.

[38]  A. Cayuela,et al.  Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis , 2006, Critical care.

[39]  Yehuda Carmeli,et al.  Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.

[40]  D. Snydman,et al.  Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study , 2001, Annals of Internal Medicine.

[41]  F. Gudiol,et al.  Epidemiology and Prognosis of Bacteremia: A 10-y Study in a Community Hospital , 2002, Scandinavian journal of infectious diseases.

[42]  Michael Y. Lin,et al.  Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia , 2008, Antimicrobial Agents and Chemotherapy.

[43]  D Greenwood,et al.  An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. , 1987, The Quarterly journal of medicine.

[44]  I. Stiell,et al.  Do β-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis , 2008 .

[45]  L. Leibovici,et al.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. , 2003, BMJ.

[46]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[47]  J. Sunderram,et al.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003* , 2007, Critical care medicine.

[48]  L. Leibovici,et al.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.

[49]  Corinne Alberti,et al.  Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity , 2004, Intensive Care Medicine.

[50]  Marin H Kollef,et al.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.

[51]  R. Venkataraman Can we prevent acute kidney injury? , 2008, Critical care medicine.

[52]  P. Petrick,et al.  Outcome of bacteraemia in patients admitted to the adult medical wards of the UKM hospital. , 2007, The Medical journal of Malaysia.

[53]  A. Moreno,et al.  Bacteremia and septic shock after solid-organ transplantation. , 2005, Transplantation proceedings.

[54]  Á. Soriano,et al.  Epidemiology and outcome of primary community-acquired bacteremia in adult patients , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[55]  W. Johanson,et al.  Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. , 1986, The American review of respiratory disease.

[56]  C. Hung,et al.  Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. , 2006, The Journal of antimicrobial chemotherapy.

[57]  H T Sørensen,et al.  Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. , 1997, Scandinavian journal of infectious diseases.

[58]  J. Rello,et al.  Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  J. Ruiz,et al.  Six-Year Prospective Study of Risk and Prognostic Factors in Patients with Nosocomial Sepsis Caused by Acinetobacter baumannii , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[60]  Á. Soriano,et al.  Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. , 2003, QJM : monthly journal of the Association of Physicians.

[61]  J. M. Porcel,et al.  Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli , 2009, Respirology (Carlton South. Print).

[62]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[63]  A. El‐Solh,et al.  Etiology of severe pneumonia in the very elderly. , 2001, American journal of respiratory and critical care medicine.

[64]  D. Macfarlane,et al.  Flavobacterium odoratum ventriculitis treated with intraventricular cefotaxime. , 1985, The Journal of infection.

[65]  J. Burke Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[66]  J. Rello,et al.  C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia , 2008, Critical care medicine.

[67]  ICU-Acquired Pneumonia Study Group,et al.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit , 1996, Intensive Care Medicine.

[68]  R. Auckenthaler,et al.  Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. , 1996, American journal of respiratory and critical care medicine.

[69]  J. Rello,et al.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.

[70]  J. Ruiz,et al.  Clinical significance of anaerobic bacteremias in a general hospital , 1993, The clinical investigator.

[71]  Jessina C. McGregor,et al.  A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  A. Candiani,et al.  Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. , 2008, American journal of infection control.

[73]  M. Struelens,et al.  Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  L. Johnson,et al.  Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[75]  J. Miro,et al.  Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia. , 1991, Antibiotics and chemotherapy.

[76]  P. Devos,et al.  Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. , 2003 .

[77]  S. Chevret,et al.  A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. , 2000, The Journal of hospital infection.

[78]  G. Hasçelik,et al.  Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli , 2005 .

[79]  Joshua A. Doherty,et al.  Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. , 2008, The Journal of antimicrobial chemotherapy.

[80]  S. Jamulitrat,et al.  Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection. , 1994, Infection control and hospital epidemiology.

[81]  Jessina C. McGregor,et al.  Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia , 2006, Antimicrobial Agents and Chemotherapy.

[82]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[83]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[84]  J. Rello,et al.  Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes , 1994, Intensive Care Medicine.

[85]  Jessina C. McGregor,et al.  Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study , 2010, PloS one.

[86]  S. Yusuf,et al.  Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction: A Meta-Analysis of the Randomized Trials , 2005, Circulation.

[87]  J. Miro,et al.  Analysis of Prognostic Factors in 274 Consecutive Episodes of Pseudomonas aeruginosa Bacteremia1 , 1991 .

[88]  P. Willcox,et al.  Community-acquired bacteraemia; a prospective survey of 239 cases. , 1988, The Quarterly journal of medicine.

[89]  J. Garnacho-Montero,et al.  Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* , 2003, Critical care medicine.

[90]  H. Dupont,et al.  Outcome of postoperative pneumonia in the Eole study , 2003, Intensive Care Medicine.

[91]  M. Niederman,et al.  Appropriateness and delay to initiate therapy in ventilator-associated pneumonia , 2006, European Respiratory Journal.

[92]  H. Brodt,et al.  Influence of antimicrobial treatment on mortality in septicemia. , 1999, Journal of chemotherapy.

[93]  Jiaquan Xu,et al.  Deaths: final data for 2006. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[94]  L. Goldani,et al.  Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study , 2006, Critical care.

[95]  J. Decruyenaere,et al.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures , 2006, Intensive Care Medicine.

[96]  J. Gatell,et al.  Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. , 1996, Archives of internal medicine.

[97]  L. Leibovici,et al.  Propensity-matched analysis of appropriate empirical antibiotic treatment. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  N. Kim,et al.  Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[99]  A. Cayuela,et al.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings , 2005, Intensive Care Medicine.

[100]  M. Kollef,et al.  Predictors of Hospital Mortality for Patients with Severe Sepsis Treated with Drotrecogin alfa (activated) , 2005, Pharmacotherapy.

[101]  I. Stiell,et al.  Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. , 2008, CJEM.

[102]  R. Bellomo,et al.  The Spectrum of Practice in the Diagnosis and Management of Pneumonia in Patients Requiring Mechanical Ventilation. Australian and New Zealand Practice in Intensive Care (ANZPIC II) , 2005, Anaesthesia and intensive care.

[103]  S. Nseir,et al.  Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[104]  Á. Soriano,et al.  Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. , 2008, The Journal of antimicrobial chemotherapy.

[105]  D. Pittet,et al.  Does antibiotic selection impact patient outcome? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  Kara E. Flavin,et al.  Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. , 2003, Chest.

[107]  J. Lowes,et al.  The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. , 1996, QJM : monthly journal of the Association of Physicians.